Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1982 1
1983 1
1985 1
1986 1
1993 1
2001 1
2002 1
2003 2
2004 5
2005 3
2006 9
2007 10
2008 11
2009 8
2010 12
2011 10
2012 16
2013 26
2014 25
2015 24
2016 25
2017 11
2018 18
2019 14
2020 23
2021 12
2022 12
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, Häußler V, Havla J, Hellwig K, Hümmert MW, Jarius S, Kleiter I, Klotz L, Krumbholz M, Paul F, Ringelstein M, Ruprecht K, Senel M, Stellmann JP, Bergh FT, Trebst C, Tumani H, Warnke C, Wildemann B, Berthele A; Neuromyelitis Optica Study Group (NEMOS). Kümpfel T, et al. J Neurol. 2024 Jan;271(1):141-176. doi: 10.1007/s00415-023-11910-z. Epub 2023 Sep 7. J Neurol. 2024. PMID: 37676297 Free PMC article. Review.
NeuroMix-A single-scan brain exam.
Sprenger T, Kits A, Norbeck O, van Niekerk A, Berglund J, Rydén H, Avventi E, Skare S. Sprenger T, et al. Magn Reson Med. 2022 May;87(5):2178-2193. doi: 10.1002/mrm.29120. Epub 2021 Dec 14. Magn Reson Med. 2022. PMID: 34904751
Advancing our commitment to our peer reviewers.
Halker Singh RB, Bobker SM, Roberts JL, Charleston L 4th, Robbins MS, Pradhan A, Sprenger T, Pozo-Rosich P, Orr SL, Powers SW, Houle TT, Turner DP, Gelfand AA. Halker Singh RB, et al. Among authors: sprenger t. Headache. 2021 Oct;61(9):1299-1301. doi: 10.1111/head.14211. Epub 2021 Oct 13. Headache. 2021. PMID: 34643953 No abstract available.
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.
Kappos L, Fox RJ, Burcklen M, Freedman MS, Havrdová EK, Hennessy B, Hohlfeld R, Lublin F, Montalban X, Pozzilli C, Scherz T, D'Ambrosio D, Linscheid P, Vaclavkova A, Pirozek-Lawniczek M, Kracker H, Sprenger T. Kappos L, et al. Among authors: sprenger t. JAMA Neurol. 2021 May 1;78(5):558-567. doi: 10.1001/jamaneurol.2021.0405. JAMA Neurol. 2021. PMID: 33779698 Free PMC article. Clinical Trial.
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values.
Rolke R, Baron R, Maier C, Tölle TR, Treede -DR, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Rolke R, et al. Among authors: sprenger t. Pain. 2006 Aug;123(3):231-243. doi: 10.1016/j.pain.2006.01.041. Epub 2006 May 11. Pain. 2006. PMID: 16697110
Daclizumab for the treatment of multiple sclerosis.
Papadopoulou A, Derfuss T, Sprenger T. Papadopoulou A, et al. Among authors: sprenger t. Neurodegener Dis Manag. 2017 Oct;7(5):279-297. doi: 10.2217/nmt-2017-0023. Epub 2017 Aug 29. Neurodegener Dis Manag. 2017. PMID: 28849702 Review.
Motion-insensitive susceptibility weighted imaging.
Berglund J, Sprenger T, van Niekerk A, Rydén H, Avventi E, Norbeck O, Skare S. Berglund J, et al. Among authors: sprenger t. Magn Reson Med. 2021 Oct;86(4):1970-1982. doi: 10.1002/mrm.28850. Epub 2021 Jun 2. Magn Reson Med. 2021. PMID: 34076922
Optimizing 3D EPI for rapid T1 -weighted imaging.
Norbeck O, Sprenger T, Avventi E, Rydén H, Kits A, Berglund J, Skare S. Norbeck O, et al. Among authors: sprenger t. Magn Reson Med. 2020 Sep;84(3):1441-1455. doi: 10.1002/mrm.28222. Epub 2020 Feb 28. Magn Reson Med. 2020. PMID: 32112447
254 results